38 Cases, 60%+ Hospitalized: Can Biotech Prevent the Next Legionnaires' Outbreak?
The NYC Legionnaires' cluster signals an urgent need for biotech innovation in rapid environmental diagnostics and antimicrobial research. With 38 cases and a 60%+ hospitalization rate, the outbreak highlights lucrative opportunities for startups and pharma companies targeting waterborne pathogens.